These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 23109394

  • 21. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.
    Chen W, Vucic E, Leupold E, Mulder WJ, Cormode DP, Briley-Saebo KC, Barazza A, Fisher EA, Dathe M, Fayad ZA.
    Contrast Media Mol Imaging; 2008; 3(6):233-42. PubMed ID: 19072768
    [Abstract] [Full Text] [Related]

  • 22. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.
    Briley-Saebo KC, Shaw PX, Mulder WJ, Choi SH, Vucic E, Aguinaldo JG, Witztum JL, Fuster V, Tsimikas S, Fayad ZA.
    Circulation; 2008 Jun 24; 117(25):3206-15. PubMed ID: 18541740
    [Abstract] [Full Text] [Related]

  • 23. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
    Jung C, Kaul MG, Bruns OT, Dučić T, Freund B, Heine M, Reimer R, Meents A, Salmen SC, Weller H, Nielsen P, Adam G, Heeren J, Ittrich H.
    Circ Cardiovasc Imaging; 2014 Mar 24; 7(2):303-11. PubMed ID: 24357264
    [Abstract] [Full Text] [Related]

  • 24. Gadospin F-enhanced magnetic resonance imaging for diagnosis and monitoring of atherosclerosis: validation with transmission electron microscopy and x-ray fluorescence imaging in the apolipoprotein e-deficient mouse.
    Jung C, Dučić T, Reimer R, Koziolek E, Kording F, Heine M, Adam G, Ittrich H, Kaul MG.
    Mol Imaging; 2014 Mar 24; 13():. PubMed ID: 25342533
    [Abstract] [Full Text] [Related]

  • 25. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, Michel JB, Corot C, Ballet S.
    Mol Pharm; 2012 Apr 02; 9(4):850-61. PubMed ID: 22352457
    [Abstract] [Full Text] [Related]

  • 26. Early animal model evaluation of an implantable contrast agent to enhance magnetic resonance imaging of arterial bypass vein grafts.
    Mitsouras D, Tao M, de Vries MR, Trocha K, Miranda OR, Vemula PK, Ding K, Imanzadeh A, Schoen FJ, Karp JM, Ozaki CK, Rybicki FJ.
    Acta Radiol; 2018 Sep 02; 59(9):1074-1081. PubMed ID: 29378421
    [Abstract] [Full Text] [Related]

  • 27. Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.
    Qiu LH, Zhang JW, Li SP, Xie C, Yao ZW, Feng XY.
    J Magn Reson Imaging; 2015 Apr 02; 41(4):1056-64. PubMed ID: 24677456
    [Abstract] [Full Text] [Related]

  • 28. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Sigovan M, Kaye E, Lancelot E, Corot C, Provost N, Majd Z, Breisse M, Canet-Soulas E.
    Invest Radiol; 2012 Sep 02; 47(9):546-52. PubMed ID: 22864378
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Magnetic resonance imaging visualization of vulnerable atherosclerotic plaques at the brachiocephalic artery of apolipoprotein E knockout mice by the blood-pool contrast agent B22956/1.
    Parolini C, Busnelli M, Ganzetti GS, Dellera F, Manzini S, Scanziani E, Johnson JL, Sirtori CR, Chiesa G.
    Mol Imaging; 2014 Sep 02; 13():. PubMed ID: 24825406
    [Abstract] [Full Text] [Related]

  • 33. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging.
    Barkhausen J, Ebert W, Heyer C, Debatin JF, Weinmann HJ.
    Circulation; 2003 Aug 05; 108(5):605-9. PubMed ID: 12835227
    [Abstract] [Full Text] [Related]

  • 34. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
    den Adel B, Bovens SM, te Boekhorst B, Strijkers GJ, Poelmann RE, van der Weerd L, Pasterkamp G.
    Atherosclerosis; 2012 Dec 05; 225(2):274-80. PubMed ID: 22882907
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.
    Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA.
    Proc Natl Acad Sci U S A; 2007 Jan 16; 104(3):961-6. PubMed ID: 17215360
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dual-probe molecular MRI for the in vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and extracellular-matrix remodeling.
    Reimann C, Brangsch J, Kaufmann JO, Adams LC, Onthank DC, Thöne-Reineke C, Robinson SP, Hamm B, Botnar RM, Makowski MR.
    Sci Rep; 2019 Sep 25; 9(1):13827. PubMed ID: 31554825
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.
    Almer G, Frascione D, Pali-Schöll I, Vonach C, Lukschal A, Stremnitzer C, Diesner SC, Jensen-Jarolim E, Prassl R, Mangge H.
    Mol Pharm; 2013 Jan 07; 10(1):175-86. PubMed ID: 23176185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.